VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012

May 29, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-05-23

Reporting Person: ALTSHULER DAVID (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-24	Stock Option	$63.14	A	30000	Acquired	2022-05-23	Common Stock (30000)	Direct

Footnotes

F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 05/24/2012.